Secondary progressive multiple sclerosis and the gut-brain axis.
暂无分享,去创建一个
[1] T. Yamamura,et al. Gut microbiota-dependent CCR9+CD4+ T cells are altered in secondary progressive multiple sclerosis , 2019, Brain : a journal of neurology.
[2] H. Lassmann. Pathogenic Mechanisms Associated With Different Clinical Courses of Multiple Sclerosis , 2019, Front. Immunol..
[3] E. Butcher,et al. Leukocyte Trafficking to the Small Intestine and Colon. , 2016, Gastroenterology.
[4] H. Weiner. A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis , 2008, Journal of Neurology.
[5] X. Montalban,et al. The value of animal models for drug development in multiple sclerosis. , 2006, Brain : a journal of neurology.
[6] D. Adams,et al. Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease , 2006, Nature Reviews Immunology.
[7] J. Newcombe,et al. Accumulation of Vα7.2–Jα33 invariant T cells in human autoimmune inflammatory lesions in the nervous system , 2004 .
[8] A. Zlotnik,et al. Mucosal Chemokines. , 2017, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.